Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

The Location of CD4 + FoxP3 + Cells with Regard to CD25 and TNFRSF25 Receptor Signals Matters: Different Requirements for GI and Peripheral Tregs

Casey O. Lightbourn, MS, Clarisel Lozano, Cameron S. Bader, BS, Sabrina N. Copsel, PhD, Dietlinde Wolf, PhD, Henry Barreras, MPH, Robert B. Levy, PhD

Blood (2019) 134 (Supplement_1): 1920.

https://doi.org/10.1182/blood-2019-131076

Published: 2019

Journal Articles

Genomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions

Noriaki Yoshida, MD PhD, Kay Shigemori, Samuel Y. Ng, MD PhD, Ajit Nirmal, PhD, Nicolas Donaldson, Nicolas Cordero, Kristen E. Stevenson, MS, Xia Bu, Mai Takeuchi, MD PhD, Koichi Ohshima, MD PhD, Akinori Yoda, PhD, David M Weinstock

Blood (2019) 134 (Supplement_1): 2760.

https://doi.org/10.1182/blood-2019-122525

Published: 2019

Journal Articles

Dissecting the Roles of p38β and p38γ in Cutaneous T Cell Lymphoma

Xu Hannah Zhang, PhD, Christiane Querfeld, MD PhD, Steven T Rosen

Blood (2018) 132 (Supplement 1): 2866.

https://doi.org/10.1182/blood-2018-99-118992

Published: 2018

Journal Articles

T Cells Engineered with a Novel Chimeric Receptor Demonstrate Durable In Vivo Efficacy Against Disseminated Multiple Myeloma

Ksenia Bezverbnaya, BSc, Vivian Lau, MSc, Craig Aarts, MSc, Galina Denisova, PhD, Arya Afsahi, MSc, Carole Evelegh, BSc, Derek Cummings, BSc, Christopher Helsen, PhD, Jonathan Bramson, PhD

Blood (2018) 132 (Supplement 1): 962.

https://doi.org/10.1182/blood-2018-99-118569

Published: 2018

Journal Articles

Development of T Cell Receptor Analysis Based Strategy to Identify Leukemia Specific Neoantigens

Lucas Gutierrez, BS, Jason Giles, MS, Miran Jang, PhD, Mojtaba Akhtari, MD, Ian Haworth, PhD, Houda Alachkar, PharmD, PhD

Blood (2018) 132 (Supplement 1): 4549.

https://doi.org/10.1182/blood-2018-99-120365

Published: 2018

Journal Articles

The Ratio of Costimulatory Vs Coinhibitory Molecules on AML Cells Determines the CD33-BiTE ® Mediated T-Cell Response

Anetta Marcinek, MSc, Bettina Brauchle, MSc, Dragica Udiljak, Roman Kischel, MD, Peter Kufer, MD, Karsten Spiekermann, MD, Michael von Bergwelt, MD, Felix S. Lichtenegger, MD, Marion Subklewe, MD

Blood (2018) 132 (Supplement 1): 1349.

https://doi.org/10.1182/blood-2018-99-116297

Published: 2018

Journal Articles

Immune Gene Expression Profiling in Children and Adults with Acute Myeloid Leukemia Identifies Distinct Phenotypic Patterns

Jayakumar Vadakekolathu, PhD, Tasleema Patel, BSc, Stephen Reeder, BSc, Heidi Schaarschmidt, BSc, Marc Schmitz, MD, Martin Bornhäuser, MD, Sarah E. Warren, PhD, Tressa Hood, MS, Patrick Danaher, PhD, Alessandra Cesano, Joseph M. Beechem, PhD, A. Graham Pockley, PhD, Sarah K Tasian, MD, Sergio Rutella, MDPhDFRCPath

Blood (2017) 130 (Supplement 1): 3942.

https://doi.org/10.1182/blood.V130.Suppl_1.3942.3942

Published: 2017

Journal Articles

Improvement of Antigen-Specific CTL Persistence By Transduction of Novel Artificial Adapter Molecule

Kotaro Miyao, MD, Seitaro Terakura, MD PhD, Keisuke Watanabe, MD PhD, Reona Sakemura, MD, Jakrawadee Julamanee, MD, Shingo Okuno, MD, Sonoko Kamoshita, MD, Erina Takagi, MD, Daisuke Koyama, MD, Tatsunori Goto, MD, Ryo Hanajiri, MD PhD, Tetsuya Nishida, MD PhD, Makoto Murata, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2016) 128 (22): 3367.

https://doi.org/10.1182/blood.V128.22.3367.3367

Published: 2016

Journal Articles

BI 836909, a Novel Bispecific T Cell Engager for the Treatment of Multiple Myeloma Induces Highly Specific and Efficacious Lysis of Multiple Myeloma Cells in Vitro and Shows Anti-Tumor Activity in Vivo

Susanne Hipp, PhD, Petra Deegen, Joachim Wahl, PhD, Diann Blanset, PhD, Oliver Thomas, Benno Rattel, PhD, Paul Adam, PhD, Matthias Friedrich, PhD

Blood (2015) 126 (23): 2999.

https://doi.org/10.1182/blood.V126.23.2999.2999

Published: 2015

Journal Articles

Distinct Signaling By Chimeric Antigen Receptors (CARs) Containing CD28 Signaling Domain Versus 4-1BB In Primary Human T Cells

Omkar Uday Kawalekar, MS, BS, Avery D. Posey, Jr., Joseph Fraietta, Jihyun Lee, John Scholler, Yangbing Zhao, Carl H. June, MD

Blood (2013) 122 (21): 2902.

https://doi.org/10.1182/blood.V122.21.2902.2902

Published: 2013

Journal Articles

Releasing CD8 + Treg Mediated Suppresssion Enhances Anti-Viral Immune Response

Tobias A.W. Holderried, MD, Hye-Jung Kim, PhD, Philipp A Lang, MD, PhD, Harvey Cantor, MD

Blood (2013) 122 (21): 2280.

https://doi.org/10.1182/blood.V122.21.2280.2280

Published: 2013

Journal Articles

Targeting CD123 In Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs ® )

Muneera H. AL Hussaini, MBBS, Julie Ritchey, Michael P. Rettig, PhD, Linda Eissenberg, PhD, Geoffrey L. Uy, MD, Gurunadh Chichili, PhD, Paul A Moore, PhD, Syd Johnson, PhD, Lynne Collins, Ezio Bonvini, John F. DiPersio, MD, PhD

Blood (2013) 122 (21): 360.

https://doi.org/10.1182/blood.V122.21.360.360

Published: 2013

Journal Articles

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Michael Schumm, DVM, Patrick Schlegel, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Carl-Philipp Schwarze, MD, Rupert Handgretinger

Blood (2013) 122 (21): 692.

https://doi.org/10.1182/blood.V122.21.692.692

Published: 2013

Journal Articles

Sustained Functional T Cell Persistence and B Cell Aplasia Following CD19-Targeting Adoptive T Cell Immunotherapy for Relapsed, Refractory CD19+ Malignacy

Michael Kalos, PhD, Bruce L. Levine, PhD, Timothy L Macatee, Irina Kulikovskaya, Erica Suppa, Bipulendu Jena, Saar I. Gill, MBBS, Laurence J N Cooper, MD, PhD, Stephan A. Grupp, MD, PhD, David L Porter, MD, Carl H. June, MD

Blood (2012) 120 (21): 756.

https://doi.org/10.1182/blood.V120.21.756.756

Published: 2012

Journal Articles

A T Cell-Engaging CD3 Recruit-Tandab Potently Kills CD19 + Tumor B Cells

Eugene Zhukovsky, PhD, Uwe Reusch, Carmen Burkhardt, Stefan Knackmuss, Ivica Fucek, Markus Eser, Fionnuala McAleese, Kristina Ellwanger

Blood (2012) 120 (21): 3721.

https://doi.org/10.1182/blood.V120.21.3721.3721

Published: 2012

Journal Articles

TCR Gene Editing Results in Effective Immunotherapy of Leukemia without the Development of GvHD

Blood (2011) 118 (21): 667.

https://doi.org/10.1182/blood.V118.21.667.667

Published: 2011

Journal Articles

Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph − B-Cell Precursor Acute Lymphoblastic Leukemia,

Chiara Palmi, Daniela Silvestri, Giulia Longinotti, Elena Vendramini, Valentino Conter, Giuseppe Basso, Andrea Biondi, MD, Maria Grazia Valsecchi, Geertruy te Kronnie, PhD, Giovanni Cazzaniga

Blood (2011) 118 (21): 3518.

https://doi.org/10.1182/blood.V118.21.3518.3518

Published: 2011

Journal Articles

Biological Features and Prognostic Impact of CRLF2 Overexpression In Childhood ALL

Giovanni Cazzaniga, Elena Vendramini, Chiara Palmi, Daniela Silvestri, Daniela Frison, Giulia Longinotti, Anna Leszl, Grazia Fazio, Emanuela Giarin, Vincenzo Rossi, Silvia Bungaro, Giuseppe Basso, Andrea Biondi, Maria Grazia Valsecchi, Valentino Conter, Truus te Kronnie

Blood (2010) 116 (21): 271.

https://doi.org/10.1182/blood.V116.21.271.271

Published: 2010

Journal Articles

Post-Transplant Cyclophosphamide Treatment Ameliorates Experimental Gvhd While Permitting Lymphopenic Expansion of Non-Host Reactive Donor T Cells.

Monica Jones, Duncan B Ross, Krishna V Komanduri, MD, Robert B. Levy, PhD

Blood (2010) 116 (21): 3751.

https://doi.org/10.1182/blood.V116.21.3751.3751

Published: 2010

Journal Articles

Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia.

Elena Provasi, PhD, Pietro Genovese, Angelo Lombardo, Zulma Magnani, Andreas Reik, Pei-Qi Liu, Victoria Chu, Jurgen Kuball, Attilio Bondanza, Giulia Casorati, Fabio Ciceri, Claudio Bordignon, MD, Philip D. Greenberg, Michael C. Holmes, Philip D. Gregory, Luigi Naldini, Chiara Bonini

Blood (2010) 116 (21): 3764.

https://doi.org/10.1182/blood.V116.21.3764.3764

Published: 2010

NARROW

The Location of CD4 + FoxP3 + Cells with Regard to CD25 and TNFRSF25 Receptor Signals Matters: Different Requirements for GI and Peripheral Tregs

Genomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions

Dissecting the Roles of p38β and p38γ in Cutaneous T Cell Lymphoma

T Cells Engineered with a Novel Chimeric Receptor Demonstrate Durable In Vivo Efficacy Against Disseminated Multiple Myeloma

Development of T Cell Receptor Analysis Based Strategy to Identify Leukemia Specific Neoantigens

The Ratio of Costimulatory Vs Coinhibitory Molecules on AML Cells Determines the CD33-BiTE ® Mediated T-Cell Response

Immune Gene Expression Profiling in Children and Adults with Acute Myeloid Leukemia Identifies Distinct Phenotypic Patterns

Improvement of Antigen-Specific CTL Persistence By Transduction of Novel Artificial Adapter Molecule

BI 836909, a Novel Bispecific T Cell Engager for the Treatment of Multiple Myeloma Induces Highly Specific and Efficacious Lysis of Multiple Myeloma Cells in Vitro and Shows Anti-Tumor Activity in Vivo

Distinct Signaling By Chimeric Antigen Receptors (CARs) Containing CD28 Signaling Domain Versus 4-1BB In Primary Human T Cells

Releasing CD8 + Treg Mediated Suppresssion Enhances Anti-Viral Immune Response

Targeting CD123 In Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs ® )

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

Sustained Functional T Cell Persistence and B Cell Aplasia Following CD19-Targeting Adoptive T Cell Immunotherapy for Relapsed, Refractory CD19+ Malignacy

A T Cell-Engaging CD3 Recruit-Tandab Potently Kills CD19 + Tumor B Cells

TCR Gene Editing Results in Effective Immunotherapy of Leukemia without the Development of GvHD

Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph − B-Cell Precursor Acute Lymphoblastic Leukemia,

Biological Features and Prognostic Impact of CRLF2 Overexpression In Childhood ALL

Post-Transplant Cyclophosphamide Treatment Ameliorates Experimental Gvhd While Permitting Lymphopenic Expansion of Non-Host Reactive Donor T Cells.

Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only